会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 10. 发明授权
    • Resolution of substituted dibenzo�b,f!thiepin-3-carboxylic acid-5-oxides
with brucine or ephedrine
    • 取代二苯并[b,f]硫杂-3-羧酸-5-氧化物与布鲁丁或麻黄碱的拆分
    • US4424355A
    • 1984-01-03
    • US351708
    • 1982-02-24
    • Patrice C. BelangerHaydn W. R. WilliamsJoshua Rokach
    • Patrice C. BelangerHaydn W. R. WilliamsJoshua Rokach
    • C07D337/14C07D405/14
    • C07D337/14Y02P20/582
    • The present invention is concerned with an improved process for the production of highly active optical isomers of (-) 7 or 8 fluorodibenzo�b,f!thiepin-3-carboxylic acid-5-oxide having the structural formula ##STR1## in which the fluoro substituent replaces a hydrogen in the 7 or 8 position. The two active isomers represented by formula II are S(-)7-fluorodibenzo�b,f!thiepin-3-carboxylic acid-5-oxide and R(-)8-fluorodibenzo�b,f!thiepin-3-carboxylic acid-5-oxide. It is especially concerned with the resolution of the racemic 7 or 8 fluorodibenzo�b,f!thiepin-3-carboxylic acid-5-oxide by first forming and separating diastereomers of said racemic carboxylic acids by salt formation with brucine or ephedrine followed by crystallization and regeneration of the desired (-) isomers and recycling of the (+) isomer by racemization of the regenerated isomer. The compounds obtained in high yield by this process are highly active prostaglandin antagonists which are useful in treating a variety of conditions such as allergic asthma.
    • 本发明涉及一种制备具有结构式“IMAGE”II的( - )7或8-氟二苯并[b,f]硫杂-3-羧酸-5-氧化物的高活性光学异构体的改进方法,其中 氟取代基取代7或8位的氢。 由式II表示的两种活性异构体是S( - )7-氟二苯并[b,f]硫杂-3-羧酸-5-氧化物和R( - )8-氟二苯并[b,f]硫杂-3-羧酸 -5-氧化物。 特别关注外消旋的7或8氟二苯并[b,f]硫杂环庚烷-3-羧酸-5-氧化物的拆分,首先通过与酪氨酸或麻黄碱的盐形成形成和分离所述外消旋羧酸的非对映异构体,随后结晶 并再生所需的( - )异构体并通过再生异构体的外消旋再循环(+)异构体。 通过该方法以高产率获得的化合物是可用于治疗多种病症如过敏性哮喘的高活性前列腺素拮抗剂。